loadpatents
name:-0.016429901123047
name:-0.0052738189697266
name:-0.001227855682373
Fryburg; David A. Patent Filings

Fryburg; David A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fryburg; David A..The latest application filed is for "treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors".

Company Profile
0.3.8
  • Fryburg; David A. - East Lyme CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors
Grant 6,967,204 - Fryburg , et al. November 22, 2
2005-11-22
Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors
App 20050070557 - Fryburg, David A. ;   et al.
2005-03-31
Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors
App 20040023989 - Fryburg, David A. ;   et al.
2004-02-05
Treatment of diabetes mellitus
Grant 6,683,080 - Fryburg , et al. January 27, 2
2004-01-27
Synergistic effect of a sulfonylurea and/or non-sulfonylurea Kchannel blocker, and a phosphodiesterase 3 type inhibitor
App 20030216294 - Fryburg, David A. ;   et al.
2003-11-20
Methods for improving efficacy of treatment with growth hormone secretagogues
App 20030199514 - Fryburg, David A. ;   et al.
2003-10-23
Synergistic effect of a sulfonylurea and/or non-sulfonylurea K+ATP channel blocker, and a phosphodiesterase 3 type inhibitor
Grant 6,610,746 - Fryburg , et al. August 26, 2
2003-08-26
Methods related to the A-C repeat Z-sequence upstream from the aldose reductase gene
App 20030114357 - Fryburg, David A. ;   et al.
2003-06-19
Use of growth hormone secretagogues in conjunction with physical exercise cross reference to related application
App 20020151551 - Fryburg, David A.
2002-10-17
Treatment of diabetes mellitus
App 20020143015 - Fryburg, David A. ;   et al.
2002-10-03
Synergistic effect of a sulfonylurea and/or non-sulfonylurea Kchannel blocker, and a phosphodiesterase 3 type inhibitor
App 20020013268 - Fryburg, David A. ;   et al.
2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed